Key result
Higher serum procalcitonin levels post-CABG were associated with increased early mortality, but risk-adjusted death at one year did not differ significantly (RR 0.068; 95% CI 0.008-0.566).
Why the study?
Increased serum procalcitonin indicates postoperative complications, motivating an evaluation of its relationship with one-year morbidity and mortality in CABG patients.
Does serum procalcitonin level predict one-year morbidity and mortality in patients after CABG surgery?
Population
100 patients undergoing CABG surgery in Birjand, Iran
Comparison
Serum procalcitonin levels
Design
Descriptive-analytical study
Follow-up
One year
Authors
Loading...
May flag early post-CABG risk; leaves open one-year prognostic value pending prospective studies.
Observational (n=100)
No
Does serum procalcitonin level predict one-year morbidity and mortality in patients after CABG surgery?
Relative Risk: 0.068 (95% CI 0.008–0.566)
Higher serum procalcitonin levels after CABG are associated with increased early mortality and sternum wound infection, though risk-adjusted death did not differ significantly at one year.
Amouzeshi et al. (2021) conducted an observational in Coronary artery bypass graft (CABG) surgery (n=100). Serum procalcitonin (PCT) level was evaluated on Risk-adjusted death after one year (RR 0.068, 95% CI 0.008-0.566). Higher serum procalcitonin levels post-CABG were associated with increased early mortality, but risk-adjusted death at one year did not differ significantly (RR 0.068; 95% CI 0.008-0.566).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: